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53BP1 can limit sister-chromatid rupture and
rearrangements driven by a distinct ultraﬁne DNA
bridging-breakage process
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Chromosome missegregation acts as one of the driving forces for chromosome instability and
cancer development. Here, we ﬁnd that in human cancer cells, HeLa and U2OS, depletion of
53BP1 (p53-binding protein 1) exacerbates chromosome non-disjunction resulting from a new
type of sister-chromatid intertwinement, which is distinct from FANCD2-associated ultraﬁne
DNA bridges (UFBs) induced by replication stress. Importantly, the sister DNA intertwine-
ments trigger gross chromosomal rearrangements through a distinct process, named
sister-chromatid rupture and bridging. In contrast to conventional anaphase bridge-breakage
models, we demonstrate that chromatid axes of the intertwined sister-chromatids rupture
prior to the breakage of the DNA bridges. Consequently, the ruptured sister arms remain
tethered and cause signature chromosome rearrangements, including whole-arm
(Robertsonian-like) translocation/deletion and isochromosome formation. Therefore, our
study reveals a hitherto unreported chromatid damage phenomenon mediated by sister
DNA intertwinements that may help to explain the development of complex karyotypes in
tumour cells.
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Gross chromosome rearrangements, as a result of chro-mosomal instability (CIN) is a hallmark of most, if not all,tumour cells; however, the underlying mechanism is not
fully understood. It is generally accepted that CIN contributes to
the initiation of tumorigenesis, metastasis progression and mul-
tidrug resistance1,2. One of the major causes of CIN can be
attributed to defects in mitosis such as chromosome mis-
alignments and chromatid non-disjunction, which manifest in
the form of lagging chromosomes and anaphase bridges. Gen-
erally, lagging chromosomes are generated because of
kinetochore-microtubule attachment errors, which not only leads
to imbalanced chromosome transmission3, but also to structural
chromosome rearrangements in both a cytokinesis-dependent
and cytokinesis-independent manner4,5. Additionally, anaphase
bridges are generated by abnormal conﬁgurations of chromo-
somes, such as fusions of chromosomes/sister-chromatid arms, or
via dysfunctional telomeres6. It has been proposed by McClintock
that anaphase bridges drive chromosomal rearrangements
through a so-called breakage-fusion-bridge (BFB) cycle, where
multiple rounds of the joined chromatid bridges break apart
during telophase (or cytokinesis) and re-fusing occurs7,8.
Recently, an elegant study has shown that the breakage of chro-
matin bridges can be triggered by a cytoplasmic nuclease, TREX1,
at telophase-G1 transition and leads to chromothripsis9.
Previously, we and others have shown that replication of stress-
induced DNA entanglements, which are associated with the
FANCD2/I dimer, can be carried into mitosis, manifesting as so-
called ultraﬁne DNA bridges (UFBs) in human anaphase
cells10–15. The resolution of which also leads to DNA damage in the
daughter offspring cells16–18. It is speculated that this is a result of
the separation of DNA intertwining structures at under-replicated
regions between sister chromatids19. Therefore, the accumulation
of DNA entanglements arising during DNA replication and/or
homologous recombination (HR) should be limited; otherwise, this
could pose substantial threats to chromosome segregation and
genome integrity. It is conceivable that this could be more pro-
blematic to cancerous cells that bear high intrinsic DNA replica-
tion/recombination activities. In fact, a recent study has shown the
association of replication stress and CIN20. Nevertheless, it remains
enigmatic how ultraﬁne DNA bridging structures may affect
faithful chromosome segregation and genome stability.
Here, we have determined that human cancer cells (HeLa and
U2OS) rely heavily on a non-homologous end-joining (NHEJ)
factor 53BP121,22, for chromosome segregation, by limiting the
formation of a new type of sister DNA intertwining structure that
is not associated with FANCD2, but is dependent of RAD51.
Intriguingly, we demonstrate that these sister DNA entangle-
ments drive a novel chromatid damage phenomenon, which
induces a rupture of the sister-chromatid axes prior to the
breakage of the intertwining DNA bridges. As a result, the rup-
tured sister chromatids remain tethered by the ultraﬁne DNA
molecules and failed to fully disjoin. Depending on the rupture-
bridging positions, this process drives typical and signature
chromosome rearrangements, including whole-arm (Robertso-
nian-like) translocations and isochromosome formation, which
are commonly observed in tumour cells. The chromatid rupture-
bridging phenomenon is also observed in several unmodiﬁed
cancer cell lines, suggesting that this alternative mitotic damage
action may contribute to the evolution of their karyotypes. In this
study, we reveal a new ultraﬁne DNA bridge-breakage process
that drives gross chromosomal rearrangements in cultured
human cancer cells, which is regulated by 53BP1.
Results
53BP1 co-localises adjacently to FANCD2 in normal S phase.
The Fanconi anaemia (FA) pathway is activated during S-phase
progression23. Previously, we showed that, under replication
stress, foci of the FANCD2/I heterodimer persist into mitosis, and
subsequently associates with a subclass of UFBs in anaphase
cells10. Furthermore, the defects in the FA pathway increase
chromosome missegregation11, implying their roles in the for-
mation of DNA intertwining structures. Unresolved DNA
entanglements can interfere with faithful chromosome segrega-
tion and genome stability. Therefore, to gain insight into how
cells prevent DNA entanglements arising during replication, we
searched for proteins that co-localise with FANCD2 during
unperturbed S phase. We found that 53BP1 forms spontaneous
nuclear foci during DNA replication in both normal diploid and
cancer cells (Supplementary Fig. 1a, b), where more than half of
them surround the FANCD2 foci (Supplementary Fig. 1c, d). This
observation suggests that 53BP1 may also participate in the
process of DNA replication and/or HR.
Generation of 53BP1Δ and 53BP1hypo cancer and normal cells.
To explore the role of 53BP1, we generated 53BP1 knockouts in
HeLa cervical carcinoma cells, U2OS osteosarcoma cells and
hTERT-immortalised RPE1 diploid cells by CRISPR-cas9 genome
editing technology. Two guide-RNAs targeting exon 2 and exon
14 of 53BP1 were used. Targeting exon 2 failed to eliminate
53BP1 expression completely in HeLa and RPE1 cells, where
residual full-length like protein, and/or small 53BP1 foci were still
detectable (Supplementary Fig. 2a–d). However, exon 2 targeting
successfully eliminated 53BP1 in U2OS cells (Supplementary
Fig. 2e, f). In contrast, targeting exon 14 efﬁciently eliminated
53BP1 expression in the above three cell lines (Supplementary
Fig. 2c, e–h). DNA sequence analysis on the 53BP1 hypomorphic
(53BP1hypo) HeLa cells detected no wild-type exon 2 sequence,
but three new mutations; all leading to premature translation
termination (Supplementary Fig. 3a–c). We thus speculated that
the 53BP1 hypomorphic expression in HeLa and RPE1 cells
might be due to a leaky expression through a downstream
alternative translation site (Supplementary Fig. 3d). Collectively,
the 53BP1Δ and 53BP1hypo in both cancer and normal cell lines
provide us with useful tools to dissect the functions of 53BP1
during DNA replication.
53BP1 depletion in HeLa and U2OS cells compromises chro-
mosome segregation and cell growth. In the absence of any
exogenous DNA assaults, we found that knocking out 53BP1
(53BP1Δ) caused pronounced chromosome missegregation phe-
notypes, including anaphase bridge and lagging chromatin for-
mation in both U2OS and HeLa cancer cells (Fig. 1a, b). These
mitotic defects were also observed in the HeLa cells expressing
hypomorphic 53BP1 protein (Fig. 1b). In addition, all 53BP1-
depleted U2OS and HeLa cancer cells, including the 53BP1hypo
cells, displayed apparent proliferation retardation (Supplementary
Fig. 4a, b). Notably, 53BP1hypo HeLa cells grew slightly better
than the complete 53BP1Δ cells (Supplementary Fig. 4c), sug-
gesting that a residual activity of 53BP1hypo protein may remain.
The mitotic and growth defect phenotypes, however, were either
not or only moderately detected in 53BP1hypo and 53BP1Δ
RPE1 cells (Fig. 1c & Supplementary Fig. 4d), indicating that
HeLa and U2OS cells exhibit a higher reliance on 53BP1 for
optimal cell division. Stable overexpression of an EGFP-tagged
53BP1 in 53BP1hypo HeLa cells largely rescued the phenotypes of
slow growth and anaphase bridges, but unexpectedly, not lagging
chromatin formation (Supplementary Fig. 5 & see explanation in
Fig. 5f–h below).
53BP1 has been shown to facilitate DNA double-stranded
break (DSB) repair mediated by the NHEJ pathway. We,
therefore, investigated whether the missegregation phenotypes
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observed might relate to the incompetency of NHEJ. In
agreement to other reports22, we found that 53BP1Δ HeLa (D4
& D10) and U2OS (B4, B18, D29 and D30) displayed increased
sensitivities to ionisation radiation (IR) treatments (Supplemen-
tary Fig. 6a, b). Similarly, moderately increased IR sensitivities
were also detected in RPE1 53BP1Δ cells (D6 and D24)
(Supplementary Fig. 6c), although they did not show severe
mitotic and growth defects. Intriguingly, we found that HeLa
53BP1hypo cells, which exhibited elevated chromosome misse-
gregation, were not sensitive to IR treatments (Fig. 1d). As
predicted, we observed colocalisation of γH2AX and hypo-
morphic 53BP1 protein at damage foci, but of a much smaller size
(Fig. 1e). In addition, the recruitment of 53BP1 to its binding
partner, hRIF124–26, was still evident in these cells
0
20
40
60
80
100
1–5
HeLa
B2 53BP1hypo
D4 53BP1Δ
D10 53BP1Δ
0%
5%
10%
15%
20%
HeLa
%
 o
f c
hr
om
os
om
es
 fu
se
d
0%
10%
20%
30%
40%
Anaphase
bridge
Lagging
chromatin
%
 A
na
ph
as
e 
ce
lls
U2OS
B4 (53BP1Δ)
B18 (53BP1Δ)
D29 (53BP1Δ)
0%
10%
20%
30%
40%
Anaphase
bridge
Lagging
chromatin
%
 A
na
ph
as
e 
ce
lls
HeLa
B2 (53BP1hypo)
D4 (53BP1Δ)
D10 (53BP1Δ)
a
f
0%
5%
10%
15%
20%
Anaphase
bridge
Lagging
chromatin
%
 A
na
ph
as
e 
ce
lls
RPE1
B7 (53BP1hypo)
D6 (53BP1Δ)
D24 (53BP1Δ)
TRF2ΔBΔM overexpression
B2(53BP1hypo)
DAPI telomere
b c
d 30 min post 2Gy IR
B2(53BP1hypo)HeLa B2(53BP1hypo)HeLa
γH2AX
53BP1
γH2AX
53BP1
Enlarged regions (same scale)
53BP1
DAPI
γH2AX
53BP1
γH2AX 53BP1 γH2AX 53BP1
53BP1
γH2AX
53BP1
γH2AXDAPI
γH2AX
e
0.01
0.1
1
0
Re
la
tiv
e
 s
u
rv
iva
l
IR (Gy)
HeLa
B2 (53BP1hypo)
53BP1hypo 53BP1Δ
**
**
***
**
*
**
**
* *
*
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
** ** %
 M
et
ap
ha
se
 s
pr
ea
d
No. of fused chromosome
B2 D10D4 6–10 11–14 16–20 21–30
1 2 43
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03098-y ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:677 |DOI: 10.1038/s41467-018-03098-y |www.nature.com/naturecommunications 3
(Supplementary Fig. 6d). Consistently, RPE1 53BP1hypo cells also
maintained IR resistance despite having very-low 53BP1 expres-
sion (Supplementary Fig. 6e). Telomere-end fusion assays
revealed that HeLa 53BP1hypo cells still exhibited a higher activity
of end-joining compared with 53BP1Δ cells, but slightly lower
than the parental HeLa cells (Fig. 1f).27,28. These results indicate
that the hypomorphic 53BP1 protein remains competent, at least
partially, in NHEJ repair of exogenously induced DSBs. There-
fore, we conclude that the increased susceptibilities to the mitotic
defects in HeLa and U2OS cancer cells after 53BP1 depletion
cannot be merely attributed to NHEJ incompetency. The high
reliance of 53BP1 activities in these cancer cell lines, is likely not
only because of its necessity for NHEJ repair, but also for a
function in facilitating chromosome segregation under physiolo-
gical growth conditions.
53BP1 suppresses sister DNA intertwining in cultured cancer
cells. We noticed that there were distinct chromatid non-
disjunction features in 53BP1-depleted cancer cells, namely a
delay of chromosome separation, manifesting as bridge-like
structures (Fig. 2a; arrows) and the formation of multiple lagging
chromatin, notably existing as a symmetric pair (Fig. 2a, b;
arrowheads). These non-disjunction patterns indicated that they
might be caused by ultraﬁne DNA intertwinements that we and
the others previously identiﬁed12,13. Immunoﬂuorescence stain-
ing of UFB-binding proteins, such as PICH and hRIF112,29,
revealed that the characteristic anaphase bridge(-like) structures
and lagging chromatin pairs were indeed tethered by UFBs
(Fig. 2c, d). As predicted, the frequency and number of UFBs
were signiﬁcantly increased in both 53BP1Δ and 53BP1hypo
cancer cells (Fig. 2e, f), suggesting that 53BP1 is required for the
suppression of UFB formation.
Chromatin bridges in anaphase can be caused by inter-
chromosomal linkage formed in dicentric or radial chromosomes,
or via sister-chromatid intertwining. To distinguish these, we
developed a protocol using EdU to differentially label one of the
two sister chromatids in mitotic cells (Fig. 3a, b). To avoid
complications arising from NHEJ malfunction, we performed
most of our investigation using HeLa 53BP1hypo cells, which, as
demonstrated above, largely maintain the NHEJ pathway.
Remarkably, almost all anaphase bridges (98%) in the HeLa
53BP1hypo cells displayed a symmetric (but opposite) staining
pattern (Fig. 3c), showing either EdU labelling on one-half of the
DNA bridge (Fig. 3d), or resembling sister-chromatid exchange
(SCE) patterns (Fig. 3e). Similarly, the lagging chromatin pairs
also displayed the symmetric labelling patterns (Fig. 3f), highly
suggesting that the non-disjoined chromatin structures are
composed of sister chromatids. Therefore, we conclude that
53BP1 acts to suppress DNA intertwinements, arising mainly
between sister chromatids. In agreement with this conclusion,
dicentric or radial chromosomes were rarely observed in
metaphase spreads of both 53BP1hypo and 53BP1Δ HeLa cells
(Fig. 3g). We henceforth name this phenomenon as “sister-
chromatid bridging” to distinguish it from the general terminol-
ogy of anaphase bridges.
The FANCD2 non-associated sister UFB is RAD51-dependent.
DNA catenation, (sister-)telomere fusion or replication stress can
lead to UFB formation19,30–32. The fact that 53BP1 accumulates
adjacently to FANCD2 foci during S phase led us to speculate that
its deﬁciency might exacerbate replication stress particularly in
these cancer cells, mimicking the effect of DNA polymerase
inhibition induced by aphidicolin treatments, which causes the
accumulation of late replication intermediates (LRIs) and the
formation of UFBs positive for FANCD2 foci10,11 (Supplemen-
tary Fig. 7a). Contrary to our hypothesis, we found that 53BP1
depletion in HeLa and U2OS cells signiﬁcantly increased ana-
phase populations having FANCD2-negative UFBs (Fig. 4a). In
contrast to aphidicolin-induced replication stress, it mainly
increased anaphase cells with FANCD2-positive, but not the
FANCD2-negative UFBs (Supplementary Fig. 7a). Consistently,
most of the UFBs (56–86%) detected in the 53BP1-depleted cells
are FANCD2 negative, except when the 53BP1hypo cells were pre-
treated with aphidicolin, which increased the proportion of UFBs
positive for FANCD2 foci from 14 to 55% (Fig. 4b & Supple-
mentary Fig. 7b). These results suggest that a new subclass of
sister DNA bridge arises in these cancer cells when 53BP1
activities become limiting. Moreover, this also indicates that the
FA pathway is not compromised in 53BP1hypo cells, which is
further supported by the fact that, like the parental HeLa, aphi-
dicolin treatment readily elevated mitotic FANCD2 foci in the
53BP1hypo cells (Supplementary Fig. 7c, d). The lack of increased
replication stress phenotypes, including spontaneously elevated
FANCD2 mitotic foci, abnormal S phase accumulation and
increased common fragile site (CFS) expression (Supplementary
Fig. 7c–f), highly suggests that the induction of FANCD2-
negative UFB formation in the 53BP1-depleted cells is unlikely
caused by the same mechanism of replication stress, induced by
DNA polymerase inhibition.
A very characteristic feature of the anaphase bridge observed in
the 53BP1hypo cells is that the sister-chromatid arms are tethered
by UFBs. We found that nearly 75% of the associated
chromosomes were positive for γH2AX signal (Fig. 4d, e),
implicating a DNA damage response acting in this phenomenon.
The fact that most of the UFB-tethered chromatin bridges arise
originally from sister chromatids and negative of FANCD2
binding infers that their formation may associate with HR
activity. To test this, we knocked down RAD51, a key initiation
factor of HR33 in HeLa 53BP1hypo cells (Fig. 4f). As shown
previously, RAD51 depletion led to increased replication stress10,
and hence elevated the anaphase population having FANCD2-
postive UFBs (Fig. 4g, h). Crucially, the RAD51 knockdown
Fig. 1 53BP1 depletion leads to increased chromosome non-disjunction in human cancer cells. Quantitation of anaphase bridge and lagging chromatin in
53BP1Δ and 53BP1hypo cells a U2OS, b HeLa and c RPE1. Numbers of cell counted: U2OS= 529, B4= 327, B18= 344, D29= 372; HeLa= 540, B2= 351,
D4= 426, D10= 317; RPE1= 435, B7= 449, D6= 382, D24= 458 from 3–4 separate preparations. d IR sensitivity assay on HeLa and B2 (53BP1hypo) cells
(N= three independent experiments). Statistical signiﬁcance was determined by two-way ANOVA. e The formation of IR-induced DNA damage foci in
HeLa and B2 (53BP1hypo) cells. Thirty minutes post 2 Gy IR, the cells were immunostained with anti-53BP1 and anti-γH2AX antibodies. Enlarged regions
demonstrating the recruitment of 53BP1 (red) at the IR-induced DNA breaks, marked by γH2AX (green). f Representative image of telomere fusions on
metaphase chromosomes of B2 (53BP1hypo) cells overexpressing TRF2ΔBΔM. An example of fusions on single (arrowheads) and both (arrows) sister
telomeres indicated (left). Middle: percentage of chromosome fusion events in HeLa, B2 (53BP1hypo), D4 and D10 (53BP1Δ) cells, >75 metaphases of each
cell line were analysed from three independent experiments. Right: histogram showing telomere fusion events in HeLa, B2 (53BP1hypo), D4 and D10
(53BP1Δ). Total number of chromosomes analysed in HeLa= 3890, B2= 3792, D4= 4720 and D10= 4790 from >60 metaphase spreads. Statistical
signiﬁcance was determined by T-test (* p< 0.0, ** p< 0.01, *** p< 0.001, ns nonsigniﬁcant). Error bars represent s.d. of three independent experiments.
Scale bars, 5 μm
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Fig. 2 Chromosome non-disjunction in 53BP1-depleted cancer cells is mediated by ultraﬁne DNA bridges. a Representative images of DAPI-stained HeLa
D4 (53BP1Δ), HeLa B2 (53BP1hypo) and U2OS B18 (53BP1Δ) cells showing anaphase bridges, bridge-like structures and lagging chromatin pairs
(arrowheads). Insets show enlarged view of the numbered cells exhibiting bridge-like (arrows; 1 & 3), bridge structures (arrow; 2). b Increased formation of
multi-lagging chromosomes in HeLa B2 (53BP1hypo) cells as compared to HeLa. Quantiﬁcation of single or multiple lagging chromatin in HeLa and B2
(53BP1hypo) cells. more than 100 cells with lagging chromatin were counted from three separate preparations. c Deconvolved high-resolution images
showing the two separating chromatin arms (red) connected by PICH-UFBs (green) in HeLa B2 (53BP1hypo, Left) and in U2OS B18 (53BP1Δ, Right). Insets
shows enlarged views of the selected region. d Deconvolved image showing hRIF1 (red) localises at a PICH-coated UFB (green), intertwining a pair of
lagging chromatin in HeLa B2 (53BP1hypo). Inset shows enlarged view of selected region. e Percentage of mid-anaphase cells with PICH-UFBs in U2OS B18
(53BP1Δ), HeLa D4 (53BP1Δ) and HeLa B2 (53BP1hypo). Numbers of anaphase counted: U2OS= 91, B18= 90; HeLa= 123, D4= 105; HeLa= 138, B2= 139
from three separate preparations. f Average number of PICH-UFB per mid-anaphase cell in U2OS B18 (53BP1Δ), HeLa D4 (53BP1Δ) and HeLa B2
(53BP1hypo). Error bars represent s.d. of three independent experiments. Statistical signiﬁcance was determined by T-test (* p< 0.05, ** p< 0.01,
*** p< 0.001). Scale bars, 5 μm
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signiﬁcantly diminished the percentage of the 53BP1hypo
anaphase cells having the FANCD2-negative UFBs (Fig. 4i).
These results indicate that the increased formation of FANCD2-
negative sister DNA bridges in 53BP1hypo cells is dependent on
the HR activity. It is plausible that (partial) loss of 53BP1 function
may increase a distinct type of replication difﬁculty, which is
converted into the sister DNA intertwinements by HR reaction.
Alternatively, 53BP1 may prevent the formation of, or facilitate
resolution of, HR intermediates (Fig. 4j). In fact, we detected
increases in SCEs in the 53BP1hypo HeLa cells (Supplementary
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Fig. 8a). However, we cannot rule out that this may be also be due
to impairments of non-crossing over resolution activity.
Contrary to our speculation, a recent report suggested that
53BP1 is required for high ﬁdelity of HR repair on double-ended
DSBs, probably through the prevention of exacerbated DNA end
resection that channels excessive single-stranded annealing (SSA)
reaction34. However, we did not detect signiﬁcant changes in the
ssDNA formation (as measured by chromatin-bound RPA) in
unperturbed 53BP1hypo S-phase cells (Supplementary Fig. 8b). It
is possible that 53BP1 may inﬂuence HR ﬁdelity differently on
double-ended and single-ended DSBs, where the latter (associated
with replication forks) is not an ideal substrate for SSA even if
excessive DNA end resection occurs. On the other hand, loss of
53BP1, as shown previously to rescue HR in brca1−/− cells35,
may further relieve the constraints of HR at damaged forks.
Nevertheless, our data demonstrate that the HR pathway
participates to a certain extent on the formation/accumulation
of the FANCD2-negative sister-chromatid bridges in the
53BP1hypo cells.
DNA intertwinements lead to sister-chromatid rupture. We
next characterised this subclass of sister-chromatid bridges and
their effects on chromosome integrity. A very striking feature of
the FANCD2-negative UFBs is that they were frequently found to
emerge at the terminal regions of the separating or lagging sister
chromatids, which could represent telomeres32. Alternatively, this
may be explained as a result of two sister arms being tethered by
UFBs, leading to their termini pointing towards each other during
segregation (Fig. 5a). According to these hypotheses, telomeres
are expected to be always present on anaphase/DNA bridges as
shown as an example in Fig. 5b. Surprisingly, telomeres were
rarely found on the DNA bridges and, indeed, they were missing
at the UFB-tethered sister chromatids (Fig. 5c, d). In contrast,
inter-chromosomal fusion generated by overexpression of
TRF2ΔBΔM, as expected, led to the majority of anaphase bridges
linking via their telomeres (Fig. 5d, e; arrows), validating our
ability to detect such events when they arise. In parallel, we
observed the loss of telomeric regions on the lagging chromatid
pairs, speciﬁcally at the chromosomal termini where the UFBs
emerged (Fig. 5f; asterisks). A simple interpretation of these
results is that the UFB-tethered sister chromatids (whether they
exist as anaphase bridges or lagging chromatin) are broken
chromosomes. Most notably, the breakage of the sister-chromatid
axes occurred at the sites where the ultraﬁne DNA linkage
emerged and persisted.
53BP1 localises to kinetochores in early mitosis36. A previous
study has reported that 53BP1 knockdown can cause
kinetochore-microtubule attachment errors and the subsequent
formation of lagging chromosomes37. However, our extensive
chromosome analyses in anaphase cells have led us to reveal an
alternative explanation for the missegregation phenotype. The
facts that genuine intact lagging chromosomes were not detected
and the presence of UFB stretching between the lagging
chromatin pairs highly indicate that the missegregation is caused
by persistent DNA intertwinements rather than kinetochore-
microtubule mis-attachment38. Because of the unexpected ﬁnding
of chromatid breakage, we re-examined the failure of an EGFP-
53BP1 wild-type protein to suppress lagging chromatin in HeLa
53BP1hypo cells (as shown in Supplementary Fig. 5d). We found
that the ectopic overexpression of 53BP1 successfully reduced the
formation of the broken lagging chromatin pairs (Fig. 5g; single
telomere end). However, it also generated extra intact lagging
chromosomes (Fig. 5g, h). Thus, the overall anaphase population
with lagging chromatin remained unchanged. These data indicate
that overexpression, but not depletion, of 53BP1 probably
interferes with proper kinetochore-microtubule attachment.
More importantly, we found that the sister DNA bridges not
only caused distinct chromatid non-disjunction, but also led to
the identiﬁcation of a new mitotic damage phenomenon, we
termed sister-chromatid rupture and bridging. Contrary to
conventional anaphase bridge-breakage models, our data clearly
show that the occurrence of DNA damage on the intertwined
sister chromatids is not coupled to the breakage of the DNA
bridges and is independent of cytokinesis.
Sister-chromatid rupture occurs strictly upon anaphase onset.
One plausible explanation for the appearance of the ruptured (but
remaining intertwined) sister chromatids during anaphase is that
they have already broken during DNA replication. If this is
correct, we should expect to see chromosomes with broken arms
or sister-chromatid arm fusion7 in (pro)metaphase cells (Sup-
plementary Fig. 9a). Of the thousands of metaphase chromo-
somes analysed on both 53BP1Δ and 53BP1hypo HeLa cells, we
found that almost all (>99.9%) were in a normal intact conﬁg-
uration (both termini were present). Only <3% of metaphases
showed evidence of a chromosome with a sister-arm fusion
(Supplementary Fig. 9b), which cannot explain the high fraction
(>30%) of anaphase cells harbouring ruptured sister-chromatid
bridges or lagging chromatin. Thus, the chromatid breakage is
inferred to occur after anaphase onset. Next, we tested if the
microtubule pulling on the intertwined chromatids causes the
rupture. We triggered premature sister-chromatid separation by
knocking down Sgo1 in 53BP1hypo (pro)metaphase cells.
Fig. 4 The formation of sister DNA entanglements in 53BP1-depleted HeLa cells is dependent on RAD51. a Quantitation of 53BP1-depleted HeLa (left) and
U2OS (right) anaphase cells forming FANCD2-negative UFBs. Numbers of anaphase counted: HeLa= 135, B2= 112, D4= 105; U2OS= 91, B18= 90 from
three independent experiments. b Maximum z-projection high-resolution image showing multiple short FANCD2-negative PICH-coated UFBs (arrows),
linking the separating chromatin and lagging chromosomes in B2 (53BP1hypo) cells. Inset shows that PICH stained UFBs (green) are not associated with
FANCD2 foci (red). c Maximum z-projection high-resolution image showing the association of FANCD2 foci (red) on PICH-UFBs (green) in aphidicolin-
treated HeLa B2 (53BP1hypo) cells. Inset shows enlarged view of PICH-coated UFBs are positive of FANCD2 foci at their termini. d Representative images
showing γH2AX present on chromatin bridges and lagging chromatin pairs in HeLa 53BP1hypo cells. Left: maximum z-projection image showing γH2AX
(red) at the junction (arrows) of the differentially labelled sister-chromatid bridges (EdU; green). Right: a pair of lagging sister chromatin intertwined by a
PICH-UFB (red) and positive of γH2AX (blue) at their termini. Bottom Right: panels showing single-plane images of the intertwining lagging sister
chromatin. Blue arrows indicate γH2AX present at the tips of the chromatin. e HeLa B2 (53BP1hypo) cell showing the presence of γH2AX signals (red) at
the termini of chromatin that were tethered by PICH-coated UFBs (green). f HeLa B2 (53BP1hypo) cells were transfected with control or Rad51 siRNA oligos,
followed by IF analysis using anti-Rad51. Nuclei are outlined (grey). g RAD51 knockdown caused the formation of FANCD2-assoicated (red) PICH-UFBs
(green) in HeLa B2 (53BP1hypo) cells. h Quantitation of HeLa B2 (53BP1hypo) anaphase cells with FANCD2-positive UFBs following RAD51 knockdown. i
Quantitation of HeLa B2 (53BP1hypo) anaphase cells with FANCD2-negative UFBs following RAD51 knockdown. Numbers of anaphase cells scored: B2 +
control siRNA= 350, B2 + RAD51 siRNA= 220 from three independent experiments. j A model showing the potential roles of 53BP1 and RAD51 in the
formation of FANCD2-negative sister DNA bridges in the 53BP1-depleted cells. Error bars represent s.d of three independent experiments. Statistical
signiﬁcance was determined by T-test (* p< 0.05, ** p< 0.01, *** p< 0.001). Scale bars, 5 μm
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03098-y
8 NATURE COMMUNICATIONS |  (2018) 9:677 |DOI: 10.1038/s41467-018-03098-y |www.nature.com/naturecommunications
Although we detected increase in chromatin breakage on single
chromatids (Supplementary Fig. 9c; 10% in HeLa and 15% in B2
53BP1hypo cells), the frequency was still lower than the observed
one in anaphase (>30%). Collectively, these data strongly indicate
that the rupture of the sister-chromatid axes occurs strictly after
anaphase onset, which may infer their damage is mediated by
factors requiring APC/C activation rather than merely spindle
pulling.
Sister-chromatid rupture exacerbates chromosomal rearran-
gements. A prediction arising from the above ﬁndings is that it
will lead to chromosomal damage and CIN in the offspring cells.
In agreement with this, we observed increased numbers of G1
53BP1 nuclear bodies in HeLa 53BP1hypo daughter cells (Sup-
plementary Fig. 9d). Additionally, we observed an increase in
numerical chromosome alterations. Interestingly, chromosome
loss, over gain, seemed to be dominant in all 53BP1hypo clones
(Supplementary Fig. 10a). Next, we examined the structural
chromosome alterations. Although, the HeLa cancer genome is
considered unstable, we found that their karyotypes are relatively
stable, as reported previously39. Whole chromosome painting and
ﬂuorescence in situ hybridisation (FISH) analyses revealed that all
HeLa cells maintained four copies of chromosome7 plus one
derivative, whereas the majority of them (94%) maintaining three
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copies of chromosome16 and a 16p derivative, (6% with two
chr16 + one derivative) (Supplementary Fig. 10b, c). However, in
the 53BP1-depleted (53BP1hypo and 53BP1Δ) HeLa cells, we
found a variety of structural rearrangements on these chromo-
somes. They included deletions and translocations on the distal
arm of 16q, chr7 and 16 whole-arm deletion, chr7 and 16 whole-
arm (Robertsonian-like) translocations and 16p/16q isochromo-
some formation (Fig. 6a–e). Crucially, such rearrangements were
never observed in the parental HeLa cells (Fig. 6f). A common
breakpoint was assigned at a site just upstream of a common
fragile site (CFS), FRA16D, in the WWOX locus, while interest-
ingly another one was mapped to, or very close to, centromeres.
Together, these results suggest that the sister-chromatid rupture
in anaphase can lead to gross chromosome rearrangements.
Chromosome rearrangements link to sister-chromatid brid-
ging. To provide further evidence that the observed rearrange-
ments are directly related to the sister-chromatid rupture/
bridging, we carefully examined the existence of DNA entangle-
ments at these regions. By extending our FISH probes along the
FRA16D/WWOX locus (Fig. 7a), we revealed a hitherto uni-
dentiﬁed DNA thread structure linking the sister chromatids in
53BP1hypo HeLa metaphase spreads (but not in the parental HeLa
cells), which presumably is a precursor of the sister DNA bridging
structures in anaphase. It was mapped at the promoter (91O9), or
the gene body (264L1), of the WWOX locus (Fig. 7b–d; arrows
and Supplementary Fig. 10d). To our knowledge, this is the ﬁrst
time that a genuine DNA intertwining molecule on cohesed sister
chromatids has been visualised and mapped. Importantly, CFS
fragility was not observed in the intertwined FRA16D locus,
which supports our above data that the intertwining molecule is
unlikely originating from an incomplete replication intermediate.
By measuring inter-sister locus distances, we determined that the
promoter region (91O9) of one WWOX allele displayed the
highest frequency of DNA thread formation, something that was
absent in a region 2.7 Mb upstream (352J17) (Fig. 7d). Correla-
tively, this new form of DNA thread structure was found in
53BP1hypo clones (B2 and b9), each of which also harboured the
corresponding rearrangements at 16q distal regions in the new
derivative chromosome. By contrast, the 53BP1hypo clone (b15)
did not show either of these features. These observations
demonstrate a high correlation between region-speciﬁc rearran-
gements and sister DNA bridging.
We next investigated whether centromeres, another hotspot of
rearrangements, also have high incidence of rupture/bridging.
Because centromeres remain cohesed in early mitosis, we
examined the chromatin bridges and lagging chromatin
structures in anaphase cells. We did not observe centromeres
on the UFB-tethered chromatin bridges. Instead, centromeres
were detected at the point at which the vast majority of lagging
chromatin was intertwined (Fig. 7e, f). Importantly, the
centromeres were located at the chromatid ends where the
telomeric regions (or the distal arms) were missing, but remained
tethered (Fig. 7g). Live-cell imaging of 53BP1hypo (B2) cells stably
expressing mCherry-H2B revealed that the lagging chromatin
pairs failed to disjoin and co-segregated into the same daughter
cell (Supplementary Fig. 10e). This is presumably due to the
persistent DNA tethering at their sister centromeres counter-
acting the spindle-separation force. The co-segregation of
ruptured sister whole-arms, thus provides an ideal precursor for
isochromosome formation that was found in these cells. Taken
together, our study reveals that the illegitimate sister DNA
entanglements can drive gross chromosomal rearrangements via
a distinct sister-chromatid rupture-bridging action that has never
been reported before.
Sister-chromatid rupture occurs in cultured cancer cells. We
next addressed if this phenomenon is limited in the 53BP1-
depleted cancer cells, or occurs generally in other unmodiﬁed
human cancer cells. We carefully characterised the mis-
segregating chromatin in anaphases of a variety of human can-
cer cell lines, including HeLa, U2OS, Saos-2 and HCT116, in the
absence of exogenous perturbation. As expected, we observed
spontaneous chromosome missegregeation in these cells, but
most importantly, we detected a subset of non-disjunction fol-
lowing a similar pattern of sister-chromatid rupture and bridging
(Fig. 7h; HeLa (10%), U2OS (7%), Saos-2 (8%) and HCT116
(13%). Thus, our results highly suggest that in addition to the
conventional anaphase bridge-breakage mechanism, sister DNA
intertwining structures may contribute to inﬂuence the complex
karyotypes during cancer evolution. Indeed, we have determined
that the HeLa genome harbours several Robertsonian(-like)
translocations or deletions, they involved chromosomes 1, 3, 7, 9,
15 and 16 (Supplementary Fig. 11), and more reported pre-
viously39. Thus, our study of sister-chromatid rupture and brid-
ging may provide an alternative explanation for their formation.
In summary, we have revealed a distinct sister-chromatid
rupture and bridging phenomenon for how ultraﬁne sister DNA
entanglements may drive excessive gross chromosome rearrange-
ments that can be suppressed by 53BP1 in cultured cancer cells
(Fig. 8). Our study may provide an alternative explanation of how
complex karyotypes arise during cancer developments in the
context of illegitimate formation and resolution of sister DNA
intertwinements.
Fig. 5 Sister-chromatid rupture is associated with HR-mediated DNA intertwining. a Diagram depicting the formation of telomere-positive DNA bridges,
resulting from DNA entanglements between sister chromatids. b A single-plane high-resolution image showing the presence of telomeres (red) at the
termini of chromatin tethered by an UFB (PICH; green) in a HeLa B2 (53BP1hypo) anaphase cell. c Maximum z-projection image of an UFB-tethered
chromatin bridge missing telomeric regions (asterisks) at their terminal ends in HeLa B2 (53BP1hypo) (left) and in U20S B18 (53BP1Δ) cells (right). Insets
show enlarged images of the DNA/chromatin bridges. d Quantitation of DAPI bridges with and without telomeres in HeLa, HeLa 53BP1hypo, U2OS 53BP1Δ
and in HeLa 53BP1hypo cells overexpressing TRF2ΔBΔM. Note: Majority of DNA bridges are negative for telomere signals in 53BP1-depleted cells, except
after TRF2ΔBΔM overexpression. Total numbers of DAPI bridge analysed were B2= 85, B2 + TRF2ΔBΔM= 60, D4= 45 and B18= 55 from three
independent experiments. Statistical signiﬁcance was determined by T-test (***, p< 0.001). e A representative image showing telomeres were detected on
chromatin bridges induced by telomere end-joining. Inset indicates the presence of telomere signals (green) at chromatin bridges (arrows). f
Representative images of HeLa B2 (53BP1hypo) cells showing UFBs tethering a pair of lagging chromatin at their termini, at where telomere (red) signals are
absent (asterisks), but remained connected by PICH-UFBs. Insets showing consecutive single z-plane images of the lagging chromatin. g Quantitation of
telomeres present at one or both ends of lagging chromatin pairs. Note that all lagging chromatin pairs lack one telomere end in HeLa B2 (53BP1hypo) and
D4 (53BP1Δ) cells. In contrast, HeLa 53BP1hypo cells stably overexpressing GFP-tagged 53BP1 (B2G53BP1) cells contain lagging chromatin having telomere
signals at both, or single ends. Total numbers of lagging chromatin pair analysed were B2= 35, D4= 41 and B2G53BP1= 44, from three independent
experiments. h Representative images of B2G53BP1 cells showing intact lagging chromosome with telomere signals (red) at both termini. Insets showing
enlarged view of the lagging chromatin with telomere signals present at both their termini. Error bars represent s.d of three independent experiments. Scale
bars, 5 μm
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Fig. 6 Gross chromosomal hyper-rearrangements mediated by sister-chromatid bridging in 53BP1-depleted cancer cells. a Formation of new chromosome
16 and 7 derivatives in HeLa 53BP1hypo and 53BP1Δ clones. Left panels: whole chromosome 16 painting revealing 16p arm deletion and arm/centromeric
translocations in HeLa b9 (53BP1hypo) cells. Middle panels: 16q deletions and arm/centromeric translocations in HeLa B2 (53BP1hypo) cells;
Isochromosome 16q formation in HeLa b15 (53BP1hypo) cells. Right panels: whole chromosome 7 painting revealing centromeric translocation in HeLa D4
(53BP1Δ) cells and arm deletion and centromeric translocation in HeLa B2 (53BP1hypo) cells. b Ideogram of human chromosome 16, marking the positions
of FISH probes used in Fig. 6c–f. c 16q distal arm deletion, centromeric translocation and 16p isochromosome formation was identiﬁed in HeLa B2
(53BP1hypo) populations with the indicated percentages. d 16p whole-arm deletion, 16q whole-arm translocation and 16q distal-arm translocation were
detected in HeLa b9 (53BP1hypo) populations with the indicated percentages. e 16q isochromosome formation was detected in HeLa b15 (53BP1hypo)
populations with the indicated percentages. f Normal chromosome 16 showing both p-arm and q-arm is maintained in all HeLa cells
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Discussion
Extensive studies report that 53BP1 facilitates repair of double-
ended DSBs via the NHEJ pathway in G1, by protecting DNA
ends from resection24–26,35, a key initiation step for HR. During S
phase, this activity is neutralised by BRCA1-CtIP, which channels
it to an error-free HR repair pathway40. In the current study, we
have identiﬁed that a new role of 53BP1, shown in HeLa and
U2OS human cancer cells, is to limit the formation of illegitimate
sister DNA entanglements, which otherwise interferes with
proper chromosome segregation. The cultured cancer cells,
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however, not normal diploid cells, are more susceptible to the loss
of 53BP1 activities, even when NHEJ function is not fully com-
promised. This may reﬂect that 53BP1 has a cell-type speciﬁc
function. Alternatively, cancerous cell lines may bear high gen-
ome instability, DNA replication demands and/or recombination
activities, which predispose the formation or accumulation of
sister DNA intertwining molecules when 53BP1 activity is lim-
ited. Indeed, transformed cells—including HeLa—are reported to
display >3-fold increase in HR activity41. A striking consequence
of 53BP1 depletion in these cancer cells is the elevation of UFB
formation that is not associated with the FANCD2 protein (a
marker of replication stress or DNA crosslinking). Interestingly,
the DNA intertwinements are still found at a common fragile site,
but this is not coupled to chromosomal fragility (the latter being a
feature of replication stress induced by DNA polymerase inhibi-
tion or DNA repair deﬁciency42–46). The lack of fragility at these
sites suggest that the new form of UFB caused by 53BP1-
deﬁciency in the cancer cells, may be fundamentally different
from those originating from LRIs. The fact that depleting RAD51
can signiﬁcantly diminish the FANCD2-negative UFBs makes us
believe that they are likely a by-product of a HR reaction.
However, we cannot rule out that there is a distinct form of
replication intermediate structure that does not trigger the FA
pathway and chromosomal fragility, and then again retains the
intertwining of sister chromatids.
It remains unclear how 53BP1 prevents illegitimate formation
of sister-chromatid bridging in the examined cancer cells. It is
plausible that (partial) loss of 53BP1 function may lead to the
formation of a distinct type of replication intermediate that is
subsequently converted by RAD51 into FANCD2-negative DNA
intertwining molecules, to prevent fork stalling or incomplete
replication. Alternatively, 53BP1 may act to suppress HR initia-
tion and/or promote resolution of HR-mediated joint molecules
during DNA replication (Supplementary Fig. 12). Extensive stu-
dies have shown that 53BP1 exerts DNA end-blocking, but is
counteracted by BRAC1-CtIP during S phase24–26,40. It is con-
ceivable that the (partial) loss of 53BP1 activity may relieve the
constraints of HR initiation at damaged replication forks. On the
other hand, loss of 53BP1 may weaken the anti-recombinogenic
and/or dHJ dissolution activities exerted via interaction of the
BLM complex47–49. Therefore, defects in one or all of these
potential activities may result in excessive formation of sister-
chromatid bridges.
Another striking ﬁnding in the current study is that the new
type of sister DNA intertwinement can drive signature chromo-
some rearrangements, notably, via a distinct chromatid damage
process. We termed this as “sister-chromatid rupture-bridging”.
Models such as BFB cycle have been proposed to explain the
development of gross chromosomal rearrangements via single or
multiple rounds of DNA damage introduced, mostly on chro-
matid arms concomitant with the breakage of anaphase bridges
during or after cytokinesis. Subsequent fusion of the broken arms
leads to re-generation of anaphase bridges and further breakages
in the next cell cycle7,8. Contrary to this mechanism, we found
that the sister DNA intertwinements induce chromatid rupture
upon anaphase onset, and unexpectedly it happens prior to the
breakage of the DNA bridges. Consequently, the ruptured sister
arms remained tethered and gave rise to the characteristic non-
disjunction chromatid products. When occurring at centromeres,
it can drive co-segregation of the ruptured whole-arm chromatin
and the formation of signature chromosomal rearrangements,
including whole-arm (Robertsonian-like) deletions/translocations
and isochromosome formation that are as-yet-unexplained
alterations observed in tumour cells50. Our ﬁndings thus pro-
vide an alternative explanation for how distinct whole-arm
rearrangements may arise from illegitimate sister DNA bridging.
It is conceivable that if the rupture-bridging phenomenon occurs
on rDNA-bearing chromosomes in germ cells, this could lead to
Robertsonian translocations that are present in a subset of Patau
and Down syndrome patients51.
Lagging chromosomes are frequently observed in tumour cells.
Based on our in-depth cytogenetic analyses, we speculate that
some of the reported lagging chromosome formation may not be
due to kinetochore-microtubule attachment errors, but due to the
persistence of sister-chromatid bridges presented here. Further
examinations will need to revisit the origin(s) of chromosome
missegregation in cancers.
CIN is generally thought to be beneﬁcial for tumour progres-
sion1,2. A recent study has shown that whole-arm deletions are
positively correlated with loss of tumour suppressor islands that
may confer growth advantages52. Undoubtedly, 53BP1 serves as a
genome stability guardian and suppresses tumourigenesis as
shown in mouse studies53,54. However, our study also indicates
that in the examined cancer cells, 53BP1 is required to prevent
excessive chromosome missegregation and probably genome
hyper-instability, and also for optimal growth. Thus, we believe
that chromosomal (hyper-)instability may need to be restrained
in cancers, (e.g. by 53BP1-mediated pathway) otherwise the
adverse effects such as chromatid intertwining and unwanted
rearrangements may hinder tumour survival ﬁtness. Thus, tar-
geting the 53BP1 pathway may be, on the other hand, a promising
therapeutic remedy in cancer treatments.
In conclusion, we show a distinct mitotic chromatid rupture-
bridging process mediated by ultraﬁne sister DNA
Fig. 7 Sister-chromatid rupture-bridging is strongly linked to distinct chromosomal rearrangements. a Positions of FISH probes at WWOX gene locus on
chromosome 16. b Representative FISH images showing DNA thread structures linking the promoter region (left) and at CFS-FRA16D site (right) of
WWOX sister alleles on HeLa B2 (53BP1hypo) metaphase chromosomes. c DNA thread structures (91O9 probe; red) were also detected in HeLa b9
(53BP1hypo) cells. Arrows indicate DNA threads linking the well-separated chromatid arms. Probe 352J17 was used as a control. d Relative distance
between sister signals of FISH probes, 352J17 and 91O9, in HeLa and 53BP1hypo cells. FISH signals showing a line or connected dot is considered as zero
distance—DNA thread formation. Eighteen metaphase spreads were counted. Note: HeLa B2 (53BP1hypo) cells retain only two intact WWOX alleles. e
Examples of centromere-tethered lagging sister chromatin in 53BP1-depleted HeLa and U2OS cells. A pair of lagging sister chromatin as differentially
labelled by EdU (green), intertwined by a PICH-UFB (red) at their centromeres (CENB, blue) in HeLa B2 (53BP1hypo) anaphase cell (Top). Pairs of broken
lagging chromatin tethered at centromeres (red) by PICH-UFBs (green) in HeLa D4 (53BP1Δ) (Middle) and U2OS B18 (53BP1Δ) cells (Bottom). f
Frequencies of lagging-chromatin pairs with UFBs linking at centromeres in HeLa 53BP1hypo and 53BP1Δ cells. Numbers of lagging chromatin pairs
analysed, B2= 49 and D4= 44 from three independent experiments. g Immuno-FISH analysis revealed loss of whole chromatid arms on lagging chromatid
pairs tethered by UFBs at centromeres. A representative image of HeLa 53BP1hypo cell showing a PICH-UFB (green) intertwines the sister centromeres
(blue) of a pair of lagging chromatin, at where the telomeres (red) are missing (asterisks). h Frequencies of sister-chromatid rupture-bridging phenomenon
in unperturbed HeLa (4/40; 10%), U2OS (3/43; 7%) and Saos-2 (2/25; 8%) cells. Representative images showing ruptured chromatin tethered by PICH-
UFBs (green), sometimes at centromeres (blue). Asterisks mark the ruptured positions at where the rest of chromatids is lost, as determined by telomere
FISH (red). Scale bars, 5 μm. Error bars represent s.d. of three independent experiments. Statistical signiﬁcance was determined by T-test (***, p< 0.001;
ns, nonsigniﬁcant)
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intertwinements that promotes characteristic chromosomal
rearrangements in 53BP1-depleted human cancer cells.
Methods
Cell culture, treatment and transfection. All cell lines were obtained from Cell
Bank of Genome Damage and Stability Centre and were originally purchased from
ATCC. All cell lines were authenticated by STR genotyping from European
Collection of Cell Cultures and passed mycoplasma tests (Lonza Mycoplasma
testing kit). HeLa, U2OS and SAOS-2 cells were grown in DMEM containing 10%
foetal bovine serum (Gibco), L-glutamine and Pen/Strep antibiotics. RPE1-hTERT
cells were grown in DMEM/F-12 containing 10% foetal bovine serum (Gibco) and
Pen/Strep antibiotics. HCT116 cells were grown in McCoy’s 5 A containing 10%
foetal bovine serum (Gibco), L-glutamine and Pen/Strep antibiotics. HeLa
B2G53BP1 cells were maintained with 0.4 mg/ml G418. Cell cultures were main-
tained at 37 °C in a humidiﬁed atmosphere containing 5% CO2. As indicated, the
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Fig. 8Models of gross chromosomal rearrangements driven by conventional anaphase bridge-breakage and sister-chromatid rupture-bridging pathways. a
Conventional anaphase bridge-breakage (also known as breakage-fusion-bridge cycle) model driven gross chromosomal rearrangements (GCRs). Aberrant
chromatids or chromosomes, such as dicentric/radial chromosomes and sister-arm fusion lead to chromatin bridge formation in anaphase. The breakage of
anaphase bridges during or after cytokinesis results in chromosome damage, which subsequently can lead to deletions, translocations and/or the re-
formation of dicentric chromosomes and sister-arm fusion. Cells enter another anaphase bridge-breakage cycle in the next mitosis that accumulate further
chromosome alterations. b Sister-chromatid rupture-bridging model driven GCRs (in the current study). Illegitimate formation/accumulation of ultraﬁne
sister DNA intertwinements lead to a symmetrical rupture of sister-chromatid axes (asterisks). The resulting sister arms remain tethered by UFB structures
resulting in anaphase bridges or lagging chromatin pairs formation (when the rupture occurs at centromeres). Further breakage may occur on the UFB-
tethered anaphase bridges in late mitosis (e.g. during abscission in cytokinesis), which lead to arm deletions or translocations. On the other hand, the
centromere-tethered lagging chromatin pairs, which lose the entire opposite arms, may escape abscission and co-segregate into one of the daughter cells.
Hence, this provides an ideal precursor for isochromosome formation, or causes whole-arm translocations in the next cell cycle. Our current model,
therefore, provides an alternative explanation on the formation of whole-arm rearrangements that may arise in cancer karyotypes
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cells were treated with the DNA polymerase inhibitor aphidicolin (Sigma, A0781;
0.3 μM).
53BP1-knockout HeLa and RPE1 cells were generated using the CRISPR-Cas9
m, with the following guide-RNAs targeting exon 2
(CAGGTTCTAGAGGATGATTCTGG) for 53BP1hypo and exon 10 (TTTATC
GTTCCTAGCAGTCC) for 53BP1Δ knockout.
Brieﬂy, gene-speciﬁc gRNAs were cloned in pSpCas9(BB)-2A-Puro (Addgene)
containing a puromycin resistance cassette. HeLa cells were transfected (Fugene
HD, Promega) and RPE1 cells were electroporated (Neon Transfection System,
ThermoFisher) with pSpCas9(BB)-2A-Puro-53BP1gRNA. Transfected HeLa,
U2OS and RPE1 cells were selected by 0.25 μg/ml and 2 μg/ml of puromycin,
respectively, for 72 h. B2 (HeLa-53BP1hypo) cells were generated by cotransfecting
pMACSKKII and pSpCas9(BB)-2A-Puro-53BP1gRNA-b in HeLa cells. Forty-eight
hours later, the cells were labelled by MACSselectKKII microbeads and enriched by
MACSselect KKII column without any antibiotic selection.
Individually isolated clones were isolated and screened by immunoblotting and
immunoﬂuorescence. The presence of mutations in knockout cells were identiﬁed
by Sanger sequencing following TA-cloning (35 clones) using primers (Fwd:
CAGGATTGGACACAACATCCTAG; Rev: CTCTCAGCAAGATACTCCTTG
CC). Primers used for 53BP1 wild-type allele-speciﬁc PCR (Fwd; AAGCCAGGT
TCTAGAGGATG; Rev: CTCTCAGCAAGATACTCCTTGCC).
To generate B2G53BP1 cells, full-length pEGFP-C3-53BP1 (isoform1) construct
was transfected in B2 (53BP1hypo) cells and were selected by G418 (0.8 mg/ml) for
2 weeks. Individual clones were screened and cultured.
HeLa or B2 cells were transfected with siRNAs using Lipofectamine RNAiMAX
(Invitrogen) following the manufacturer's instruction. The sequences of stealth
siRNAs (ThermoFisher) are as follows:
RAD51 (CCACCAGACCCAGCUCCUUUAUCAA),
Non-targeting pool (UGGUUUACAUGUCGACUAA,UGGUUUACAUGU
UGUGUGA, UGGUUUACAUGUUUUCUGA and UGGUUUACAUGUUU
UCCUA).
Fluorescence immunostaining. For immunostaining analyses, the cells were
seeded onto No:1.5 H cover glass and ﬁxed with PFA buffer (250 mM HEPES, 1x
PBS, pH7.4, 0.1% Triton X-100, 4% methanol-free paraformaldehyde) for 20 min at
4 °C or with room temperature PFA buffer (1x PBS, 4% methanol-free paraf-
ormaldehyde) for 10 min. Pre-extraction was carried out in indicated experiments
before ﬁxation by incubation of the cover glass into pre-extraction buffer (20 mM
HEPES, pH 7.4, 0.5% Triton X-100, 50 mM NaCl, 3 mM MgCl2, 300 mM sucrose)
for 15 sec.
Primary antibodies used: anti-FANCD2 (Novusbio NB100-82; 1:600), anti-
53BP1 (Abcam ab36823; 1:800), anti-53BP1 (Bethyl Lab A300-272A; 1:1000), anti-
53BP1 (Millipore MAB3802; 1:800), anti-53BP1 (Santa Cruz H-300; 1:400), anti-
RIF1 (Bethyl Lab A300-568A-3; 1:200), anti-PICH (Abnova H00054821-B01P;
1:150), anti-PICH (Abnova; H00054821-D01P; 1:100), anti-γH2AX (Upstate JBW-
301; 1:400), anti-RAD51 (Abcam ab63801; 1:200), anti-RPA70 (Abcam ab79398;
1:200), anti-CENPB (Abcam ab25734; 1:600) and anti-centromere (ImmunoVision
HCT-0100; 1:800). All secondary antibodies were used in a dilution of 1:500 and
purchased from ThermoFisher Scientiﬁc, unless stated otherwise. Secondary
antibodies used: donkey anti-mouse Alexa Fluor 488 (A-21202), 555 (A-31570)
and 647 (A-31571); donkey anti-rabbit Alexa Fluor 488 (A-21206), 555 (A-31572)
and 647 (A-31573); donkey anti-goat Alexa Fluor 555 (A-21432); goat anti-rabbit
Abberior STAR 635 P (Abberior 2-0012-007-2) and goat anti-human DyLight 550
(Abcam ab96908) and 650 (Abcam ab96910). Immunoﬂuorescence staining was
performed according to previously described protocols13. In brief, the samples were
incubated with primary antibodies at 37 °C for 90 minutes and rinsed with 1 × PBS
followed by incubation of secondary antibodies in room temperature for 25
minutes. The cells were mounted using Vectasheild containing DAPI.
High-resolution deconvolution microscopy. Image acquisition was carried out
under a Zeiss AxioObserver Z1 epiﬂuorescence microscopy system with 40 × /1.3
oil Plan-Apochromat, 63 × /1.4 oil Plan-Aprochromat and 100 × /1.4 oil Plan-
Aprochromat objectives and a Hamamatsu ORCA-Flash4.0 LT camera. The system
is calibrated and aligned by using 200 nm-diameter TetraSpeck microspheres
(ThermoFisher). Z-stack images were acquired at 0.2 μm intervals covering a range
from 3–8 μm by using ZEN blue software.
Deconvolution was carried out using Huygens Professional deconvolution
software (SVI) with a measured point-spread-function generated by 200 nm-
diameter TetraSpeck microspheres. Classical maximum likelihood estimation
method with iterations of 40–60 and signal-to-noise of 20–40 was applied.
Anaphase bridges and lagging chromosomes counting. Cells were grown on
coverslips for 18 h and ﬁxed with 4% paraformaldehyde in 1X PBS at room tem-
perature for 10 min. The cells were then stained with Hoechst 33342 and slides
were mounted in Vectashield mounting medium. Anaphase cells with chromatin
bridges and lagging chromatin were scored under Zeiss Axio Observer Z1
microscope. The counting was completed by three different assessors between
experiments. The cells were counted from random microscopic ﬁelds.
Differential sister-chromatid labelling on mitotic cells. Differential labelling of
sister chromatids was performed by modifying the cell synchronisation method of
a double thymidine arrest. Brieﬂy, the cells were incubated with EdU during the
second thymidine arrest period. EdU was then maintained following the release
and washed away after 9 h of incubation. After 24–26 h, the samples were collected
for metaphase spread preparation or anaphase cell ﬁxation as mentioned before
and subjected to immunoﬂuorescence staining and microscopy analysis.
EdU was detected using Click-iT Plus EdU labelling kits (Alexa Fluor 488, 555
or 647). For EDU pulse labelling, the cells were treated with EdU (10 μM) 10–15
min prior to ﬁxation. EdU staining was performed according to the manufacturer’s
instruction.
Immunoblotting. Cells were trypsinized and lysed on ice for 20 min with lysis
buffer (50 mM Tris, pH 7.5, 300 mM Nacl, 5 mM EDTA, 1% Triton X-100, 1.25
mM DTT, 1 mM PMSF and cOmpleteTM protease inhibitor cocktail). Protein
concentration was quantiﬁed using Bradford assay (Bio-Rad). Immunoblotting (IB)
was performed following standard procedures. Primary antibodies used for IB in
this study: anti-53BP1 (Abcam, ab36823; 1:7000), anti-53BP1 (Santa Cruz, H-300;
1:800), anti-Ku80 (Abcam, ab80592; 1:10000) and anti-β-actin (Sigma, A5316;
1:5000).
Secondary antibodies used: goat anti-rabbit HRP (Amersham NA9340V;
1:25000) and goat anti-mouse HRP (Abcam ab6789; 1:10000).
MTT proliferation assay. Cell proliferation was assessed using MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). Brieﬂy, the cells were
seeded in triplicate on a 24-well plate and 50 μl of 0.5 g/L MTT was added at
indicated times. After incubation at 37 °C for 2 h, the MTT medium was aspirated
and 250 μl of DMSO was added to each well. The absorbance was measured using
CLARIOstar plate reader (BMG Labtech) at 595 nm.
Clonogenic cell survival and Micro-colony formation assay. For clonogenic cell
survival assay, HeLa, U2OS and its derived 53BP1 knockout cells or RPE1 and its
derived 53BP1 knockout cells were plated in 10‐cm tissue culture petri dishes. Five
hours later, the cells were treated with different doses of irradiation using an X-ray
machine. The treated cells were allowed to grow for 15 days to form colonies. The
colonies were ﬁxed with 70% ethanol and stained with 1 mg/ml bromophenol blue
for 2 h.
For micro-colony formation assay, ~50 single cells were seeded onto a coverslip
(24 × 24 mm) to form colonies. After 7 days, the cells were stained with CellMask™
Deep Red (ThermoFisher Scientiﬁc) and ﬁxed with PFA. The cells were mounted
in DAPI Vectasheild and captured under a 40 × objective using 3 × 3 tiling to image
the whole colony size in an area of 900 × 900 μm2.
Metaphase spread preparation. Cells were collected for metaphase spread pre-
paration after 1 h of colcemid (Gibco, 0.5 µg/ml) treatment and were swelled with
pre-warmed KCl (0.075M) hypotonic solution at 37 °C for 5 min. The cells were
washed twice and ﬁxed with 3:1 methanol:acetic acid. The cells were dropped onto
glass slides. For chromosome number frequency the metaphase spreads from
random microscopic ﬁelds were counted.
Telomere end-to-end fusion assay. For telomere fusion assay pLPC-NMYC
TRF2ΔBΔM construct (Addgene) was transiently transfected in HeLa or B2
(53BP1hypo) for 36 h using Fugene HD. Following transfection, the cells were
harvested for metaphase spread preparation and quantitation after FISH staining
(described below).
Fluorescence in situ hybridisation (FISH). Bacterial artiﬁcial chromosome (BAC)
clones were purchased from BACPAC resources centre, C.H.O.R.I. BAC DNA was
isolated using QIAGEN® Plasmid Puriﬁcation MaxiPrep kit. A volume of 1 μg of
BAC clone DNA was labelled by nick translation for 90 min at 15 °C with
digoxigenin-11-dUTP (Roche) using a nick translation kit (Roche) or ATTO
labelling kit (Jena Bioscience). Labelled probe together with cot-1 DNA (Roche)
was dehydrated. The denatured probe was re-suspended in hybridisation buffer
and placed on a metaphase slide (prepared as described earlier), which had been
dehydrated in a graded ethanol series (70%, 85% and 100%). The slide was sealed,
denatured (82.5 °C for 2 min) and incubated O/N at 37 °C. The slide was washed at
65 °C in 0.1 × SSC. DIG-labelled probe was detected with FITC-conjugated anti-
digoxigenin for 30 min at RT. Chromosomes were counterstained with DAPI
Vectasheild.
Peptide nucleic acid (PNA) ﬂuorescent in situ hybridisation. PNA probes were
hybridised according to the manufacturer’s instructions telomere-CY3 (DAKO,
Agilent technologies) or FAM488-CENPB (PNAbio). Brieﬂy, metaphase slides
were washed in TBS buffer, ﬁxed in 3.7% PFA and dehydrated in a graded ethanol
series (70%, 85% and 100%). The slides were air dried and hybridised with PNA
probe and co-denatured (80 °C for 2 min) and incubated for 2 h at room tem-
perature. Chromosomes were counterstained with DAPI Vectasheild.
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Immuno-FISH. Immuno-FISH was performed after standard IF-staining proce-
dures. Brieﬂy, the cells were subjected to immunoﬂuorescence as described above
and re-ﬁxed with 8% paraformaldehyde at room temperature for 10 min. The
samples were co-denatured with 10 μl of Cy-3-labelled telomere speciﬁc PNA
probe (80 °C for 5 mins) and hybridised for 2 h at room temperature in the dark.
The cells were then washed and mounted with DAPI Vectasheild.
Flow cytometry. The cells were trypsinised, washed with PBS and ﬁxed with 70%
ice-cold ethanol. For cell cycle analysis, the cells were washed with PBS and re-
suspended in PI/RNase staining buffer. FACS proﬁle were then determined and
analysed using BD accuri C6 sampler.
Statistics. Statistical analysis was performed using GraphPad Prism software by
two-tailed unpaired Student’s t-test or two-way Anova as per the experimental
requirement. Data were presented as the mean + s.d. unless speciﬁed. Probability
value ‘p ≤ 0.05’ was considered to be signiﬁcant.
Data availability. All the data and materials supporting this work are available
upon reasonable request to the corresponding author.
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